ClinicalTrials.gg
RecruitingNCT06032455Updated Apr 13, 2026

Effectiveness of Multisystemic Therapy for Adolescents From Families With Intellectual Disabilities

An observational study in Behavioural Problems, sponsored by De Viersprong. Recruiting at 4 sites in Netherlands. Open to participants aged 10 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-04-13.

Primary conditionIntellectual DisabilityRegistry: Mental DisordersReclassifiedWhy we changed it
Registry
Mental Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Intellectual Disability
Why
  1. The study's title name Intellectual Disability, a narrower term within Mental Disorders.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by De Viersprong · Observational

From the registry’s dates

  • Started Sep 2023; still recruiting 3 years 2 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
470
Ages
10 Years to 19 Years
Sex
All
01

Study summary

The goal of this observational study is to determine the effectiveness of a specialisation of multisystemic therapy (MST) for adolescents with severe behavioural problems from families with an intellectual disability (ID; MST-ID).

To achieve this goal, a mixed method study design is used. To this end, a quantitative and a qualitatively primary research question are formulated:

  • Is MST-ID superior, when compared to standard MST, in reducing rule-breaking behaviour of adolescents (quantitative)?
  • What are the experiences of adolescents and/or parents receiving MST-ID treatment (qualitative)?

Participants will be asked to complete two screeners (questionnaires delivered as a verbal interview) with a total duration of approximately 30 minutes. Other data will be collected through Routine Outcome Monitoring questionnaires that are part of standard MST procedures. To this end, five 'time points' have been identified: T0 (start of MST[-ID] treatment), T1 (end of MST[-ID] treatment), T2 (follow-up 6 month after MST[-ID] treatment), T3 (follow-up 12 month after MST[-ID] treatment), and T4 (follow-up 18 month after MST[-ID] treatment). The qualitative method used to gain insight into families' experiences is determined in consultation with the families.

To assess the effectiveness of MST-ID, its treatment outcomes will be compared to standard MST treatment outcomes of families with ID.

Read the detailed description

Background of the study:

Over the years, a large body of research has shown that adolescents with intellectual disability are 3-4 times more likely to develop severe behaviour problems than adolescents without intellectual disability. Families in which adolescents and/or one or both parent(s) have an intellectual disability (from now on, families with ID) often deal with complex problems, putting the adolescent at an increased risk of out-of-home placement. Multisystemic therapy (MST) is an intensive home-based treatment, effective in reducing severe behaviour problems and preventing the out-of-home placement of adolescents. A specialisation of MST has been developed for families with ID: MST-ID. In MST-ID, among other alterations, simplified language and visual support is used, sessions are more structured and more time is scheduled for practicing exercises, and extra attention is paid to the generalisation of what has been learned in the sessions (with the aim of attaining long-term outcomes). Pilot studies show that when compared to standard MST, MST-ID shows similar or better treatment outcomes in families with adolescents with ID. Meanwhile, MST-ID has been disseminated more widely and the target population extended by including families in which only the parent(s) have an ID.

Objective of the study:

The aim of this study is to investigate the effectiveness of MST-ID for adolescents with severe behavioural problems from families with an intellectual disability (ID), compared to standard MST. It is hypothesised that MST-ID is more effective - in terms of fewer behavioural problems, more adolescents living at home, being in school/work, no new police contacts, less parenting stress - than standard MST. Treatment outcomes are considered both quantitatively and qualitatively.

Study design:

Quantitatively, the Propensity Score (PS) method is used to balance treatment groups and, combined with Multilevel Modelling (MLM), to estimate treatment effect over time. Qualitatively, the experiences of approximately 10 adolescents and/or parents are centralised. The qualitative research methods will be decided upon in a participatory manner with respondents (examples of potential research methods are interviews, focus group discussions, or photo elicitation).

Study population:

Adolescents (10-19y) with severe behavioural problems or delinquent behaviours, and their parent(s) receiving MST(-ID) treatment. All research participants must be from families where either the adolescent and/or parent(s) has/have ID.

Intervention:

Following standard referral procedures, families were either referred to standard MST or MST-ID treatment (i.e., non-randomly). Both standard MST and MST-ID are intensive, home-based treatments with 3-5 home visits per week, targeting the severe behavioural problems of adolescents across multiple life domains. MST-ID is tailored to the needs and skill deficits of adolescents and/or parents with ID. Concretely, more attention is paid to how therapists create engagement, implement interventions, and realise support from informal supports, in a tailored, developmentally appropriate, and simplified manner (meaning in a more structured way and using accessible language, among others), when compared to standard MST.

Research questions:

Building on the objectives, the following research questions were formulated:

Primary research questions:

  1. Is MST-ID superior, when compared to standard MST, in reducing rule-breaking behaviour of adolescents, according to parents?
  2. Is MST-ID superior, when compared to standard MST, in reducing rule-breaking behaviour of adolescents, according to adolescents?

    Secondary research questions:

  3. Is MST-ID superior, when compared to standard MST, in reducing externalising and internalising behavioural problems of adolescents, according to parents?
  4. Is MST-ID superior, when compared to standard MST, in reducing externalising and internalising behavioural problems of adolescents, according to adolescents?
  5. Is MST-ID superior, when compared to standard MST, in reducing parenting stress?
  6. Is MST-ID superior, when compared to standard MST, in preventing short and long term out-of-home placement, delinquency, truancy or joblessness, and addictions of adolescents?
  7. Is MST-ID superior, when compared to standard MST, in realising improvements on family's social networks?
  8. Is MST-ID superior, when compared to standard MST, in improving the instrumental outcome parenting skills?
  9. Is MST-ID superior, when compared to standard MST, in improving the instrumental outcome family relations?
  10. Is MST-ID superior, when compared to standard MST, in improving the instrumental outcome social support?
  11. Is MST-ID superior, when compared to standard MST, in improving the instrumental outcome adolescent success in an educational or vocational setting?
  12. Is MST-ID superior, when compared to standard MST, in improving the instrumental outcome adolescent involvement with pro-social peers?
  13. Is MST-ID superior, when compared to standard MST, in improving the instrumental outcome change in adolescent problem behaviour?
  14. What are the experiences of adolescents and/or parents receiving MST-ID treatment?
  15. Do effects across subgroups of adolescents and/or parents with ID differ?

MST-ID is expected to be superior in achieving the aforementioned outcomes (#1-13) when compared to standard MST. Research questions #14-15 will be assessed exploratively, therefore no hypotheses have been formulated.

02

Conditions studied

  • Behavioural Problems

Browse trials for

Keywords

  • multisystemic therapy
  • intellectual disability
  • adolescent behavioural problems
  • family functioning
03

In context

Intellectual Disability Reclassified

387 studies on the registry are indexed under Intellectual Disability; 105 are open to participants now.

This study's planned enrollment of 470 is above the median of 150 across 125 observational studies indexed under Intellectual Disability.

Browse Intellectual Disability studies →

Lead sponsor

De Viersprong is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Compared within Intellectual Disability, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Mental Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
10 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The target population consists of adolescents and their parent(s) with a known or suspected ID referred to MST-ID at one of three Dutch mental health care organisations (de Viersprong, Koraal, and Prisma) or to standard MST at one of two Dutch mental health care organisations (de Viersprong and Pactum).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Referral Criteria:

  • Known or suspected ID of the referred adolescent and/or their parent(s);
  • Educational level of the referred adolescent and/or highest attained diploma of their parent(s) is indicative of potential ID.

Inclusion criteria

Inclusion Criteria Study Sample:

  • Adolescent must be 10 to 19 years old at the start of treatment;
  • Adolescent presents with severe behavioural problems in at least two life areas;
  • Adolescent lives with a family or there is a family the adolescent can live with, in which parent(s) have parental custody for a longer period of time;
  • Parent(s) consent(s) and is/are willing to engage in treatment to prevent an out-of-home placement of the adolescent;
  • Adolescent and/or parent(s) have a known or suspected intellectual disability (operationalised as an intelligence quotient [IQ] score of between 50-85 and additional deficits in adaptive functioning)
  • Adolescent and/or parent(s) have sufficient knowledge of the Dutch language (as assessed by a clinician and/or researcher) in order to understand and answer the various (self-report) questionnaires.

Exclusion criteria

Exclusion Criteria Study Participation:

  • Adolescent lives independently;
  • Adolescent presents with severe problematic sexual behaviours, without presenting with other severe behavioural problems;
  • Adolescent presents suicidal, psychotic, or homicidal requiring specialised treatment (such as a crisis placement in a residential facility);
  • Adolescent has a severe Autism Spectrum Disorder (level 2-3 according to the [DSM-V] criteria) or a severe ID (IQ score \<50);
  • Adolescent has internalising psychiatric problems which are the primary reason for referral, or has serious psychiatric problems (similar to #3 as well as for example eating disorder.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
470 participants (estimated)
Patient registry
No

Groups and cohorts

  • Families receiving standard MST

    Families in which the adolescent and/or parent(s) has/have an ID receiving standard MST treatment

    Behavioral: Multisystemic therapy

  • Families receiving MST-ID

    Families in which the adolescent and/or parent(s) has/have an ID receiving MST-ID treatment

    Behavioral: Multisystemic therapy - intellectual disabilities

Interventions

  • BehavioralMultisystemic therapy

    Multisystemic Therapy (MST) is an intensive, evidence-based treatment aimed at preventing out-of-home placement of adolescents with severe behavioural problems. The intervention is home-based and focuses not only on the adolescent, but also on the various systems surrounding the adolescent, such as the family, neighbourhood, school, and friends. MST helps parents increase their parenting competencies such as parental monitoring and find (more) social support in their environment. MST also helps adolescents improve their relationship with their parents, school participation, and social activities, and promotes contact with pro-social peers. These goals are achieved by working together with key figures in the family's environment. MST treatment duration is three to five months. In MST, a family can contact a therapist 24/7.

    Also known as: MST

  • BehavioralMultisystemic therapy - intellectual disabilities

    Multisystemic therapy - intellectual disabilities (MST-ID) is a specialisation of standard MST (see above), tailored to the needs and skill deficits of families in which the adolescent and/or parent(s) has/have a known or suspected ID. In MST-ID, among others, simplified language and visual support are used, and extra attention is paid to the generalisation of what has been learned in the treatment sessions.

    Also known as: MST-ID

06

What researchers measure

Primary outcomes

  1. Rule-breaking behaviour of adolescents - parents

    Rule-breaking behaviour of adolescents according to parents will be assessed using the Child Behavior Check List (CBCL). The CBCL consists of 118 questions rated on a 3-point scale from 0 (absent) to 2 (occurs often). Higher scores indicate that adolescents experience more problems.

    Time frame: Start of MST(-ID) treatment (T0) until 18-month follow up (T4)

  2. Rule-breaking behaviour of adolescents - adolescents

    Rule-breaking behaviour of adolescents according to parents will be assessed using the Youth Self Report (YSR). The YSR consists of 112 questions rated on a 3-point scale from 0 (absent) to 2 (occurs often). Higher scores indicate that adolescents experience more problems.

    Time frame: Start (T0) and end (T1) of MST(-ID) treatment, an average of 4 months in between

Secondary outcomes

  1. Externalising and internalising behavioural problems of adolescents - parents

    Externalising and internalising behavioural problems of adolescents will be assessed using the Child Behavior Check List (CBCL). The CBCL consists of 118 questions rated on a 3-point scale from 0 (absent) to 2 (occurs often). Higher scores indicate that adolescents experience more problems.

    Time frame: Start of MST(-ID) treatment (T0) until 18-month follow up (T4)

  2. Externalising and internalising behavioural problems of adolescents - adolescents

    Externalising and internalising behavioural problems of adolescents according to adolescents will be assessed using the Youth Self Report (YSR). The YSR consists of 112 questions rated on a 3-point scale from 0 (absent) to 2 (occurs often). Higher scores indicate that adolescents experience more problems.

    Time frame: Start (T0) and end (T1) of MST(-ID) treatment, an average of 4 months in between

  3. Parenting stress

    Parenting stress will be assessed using the Parenting Stress Questionnaire (PSQ), which is the English version of the Dutch Opvoedingsbelasting Vragenlijst (OBVL). The PSQ consists of 34 questions rated on a 4-point scale from 1 (not true) to 4 (very true). Higher scores indicate more parenting stress.

    Time frame: Start of MST(-ID) treatment (T0) until 18-month follow up (T4)

  4. Out-of-home placement

    Out-of-home placement of adolescents will be assessed using the Social Demographic Information 3.0 questionnaire (SDI 3.0).

    Time frame: Start of MST(-ID) treatment (T0) until 18-month follow up (T4)

  5. Delinquency

    Delinquency of adolescents is operationalized as police contact and will be assessed using the SDI 3.0.

    Time frame: Start of MST(-ID) treatment (T0) until 18-month follow up (T4)

  6. School going or work

    The adolescent's school going or work is operationalised as "school going that meets the expectations of the school or public education law officer or work that meets the expectations of caregivers and the referring agent" and will be assessed using the SDI 3.0.

    Time frame: Start of MST(-ID) treatment (T0) until 18-month follow up (T4)

  7. Addictions

    Addictions of adolescents are operationalised as "adolescent drug misuse/abuse, screen or game dependency that has resulted in addiction, and/or other addictions" and will be assessed using the SDI 3.0.

    Time frame: Start of MST(-ID) treatment (T0) until 18-month follow up (T4)

  8. Social network

    Social network is operationalised as "forms of social network available to a family and number of supports (read: individuals) that are available to the family" and will be assessed using the SDI 3.0.

    Time frame: Start of MST(-ID) treatment (T0) until 18-month follow up (T4)

  9. IO Percentage of families with improved parenting skills

    MST's so called "instrumental outcomes" (IOs) identify skills which are instrumental to achieving positive treatment outcomes and are reported by therapists. The first IO assesses whether or not families show improved parenting skills, answered 'yes' or 'no'.

    Time frame: End of MST(-ID) treatment, an average of 4 months after start of treatment

  10. IO Percentage of families with improved family relations

    MST's so called "instrumental outcomes" (IOs) identify skills which are instrumental to achieving positive treatment outcomes and are reported by therapists. The second IO assesses whether or not families show improved family relations, answered 'yes' or 'no'.

    Time frame: End of MST(-ID) treatment, an average of 4 months after start of treatment

  11. IO Percentage of families with improved social support

    MST's so called "instrumental outcomes" (IOs) identify skills which are instrumental to achieving positive treatment outcomes and are reported by therapists. The third IO assesses whether or not families show improved social support, answered 'yes' or 'no'.

    Time frame: End of MST(-ID) treatment, an average of 4 months after start of treatment

  12. IO Percentage of families with adolescent success in an educational or vocational setting

    MST's so called "instrumental outcomes" (IOs) identify skills which are instrumental to achieving positive treatment outcomes and are reported by therapists. The fourth IO assesses whether or not the adolescent obtained success in an educational or vocational setting, answered 'yes' or 'no'.

    Time frame: End of MST(-ID) treatment, an average of 4 months after start of treatment

  13. IO Percentage of families with adolescent involvement with pro-social peers

    MST's so called "instrumental outcomes" (IOs) identify skills which are instrumental to achieving positive treatment outcomes and are reported by therapists. The fifth IO assesses whether or not the adolescent is involved with pro-social peers, answered 'yes' or 'no'.

    Time frame: End of MST(-ID) treatment, an average of 4 months after start of treatment

  14. IO Percentage of families with change in adolescent problem behaviour

    MST's so called "instrumental outcomes" (IOs) identify skills which are instrumental to achieving positive treatment outcomes and are reported by therapists. The sixth IO assesses whether or not the adolescent obtained changes in problem behaviour that were sustained for 3-4 weeks, answered 'yes' or 'no'.

    Time frame: End of MST(-ID) treatment, an average of 4 months after start of treatment

Other outcomes

  1. Family and treatment characteristics

    Characteristics of families that are gathered are previous treatment, referral stream and the following: Adolescent: age, gender identity, cultural background, prior residential placement, living situation, level of education Primary caregiver: level of education, employment status, partner, experienced financial stress, experienced living situation stress

    Time frame: Start of MST(-ID) treatment (T0)

  2. Intellectual functioning

    Intellectual functioning will be assessed using the Dutch Screener for Intelligence and Learning Disabilities (SCIL). The SCIL consists of 14 questions that result in a total SCIL score that can range from 0 to 28. A total SCIL score of 19 and below indicates the presence of intellectual disabilities.

    Time frame: Start of MST(-ID) treatment (T0)

  3. Adaptive functioning

    Adaptive functioning will be assessed using the Dutch Screener for Adaptive Functioning and Learning Disabilities (SCAF). The SCAF consists of 12 questions that result in a total SCAF score that can range from 0 to 13. A higher score indicates a higher level of adaptive functioning.

    Time frame: Start of MST(-ID) treatment (T0)

  4. Treatment fidelity

    Treatment fidelity is measured and checked through administration of a validated questionnaire to the primary caregiver of each family (TAM-R).

    Time frame: Monthly throughout MST(-ID) treatment, an average of 4 months

  5. Subgroups of ID families

    Families included in this study are divided across three subsamples: families in which only the adolescent, only the parent(s), and both the adolescent and parent(s) have ID. This This variable will be calculated based on participants' SCIL scores.

    Time frame: Start of MST(-ID) treatment (T0)

  6. Experiences of families receiving MST-ID

    Experiences of families receiving MST-ID will be assessed using participatory and qualitative research methods. The aim is to recruit 10 adolescents or parents and to ask them to help identify which elements of MST-ID are most important to them, and which elements were found least and most helpful. This can lead to a better understanding of what works well and less well in MST-ID treatments. Potential qualitative research methods are focus group discussions, peer-interviewing, and photo-elicitation/photo voice.

    Time frame: Through study completion, an average of 1 year

07

Study locations

4 of 4 sites recruiting
  • De Viersprong
    Halsteren, Netherlands
    Recruiting
    • Dineke J Feenstra, PhD · Contact+31887656200
  • Koraal
    Sittard, Netherlands
    Recruiting
    • Gaby van Helvert · Contact+31464775252
  • Stichting Prisma
    Waalwijk, Netherlands
    Recruiting
    • Mariska Mecking · Contact+31629547022
  • Pactum
    Zetten, Netherlands
    Recruiting
08

References and documents

Publications

  • Emerson E, Einfeld S, Stancliffe RJ. Predictors of the persistence of conduct difficulties in children with cognitive delay. J Child Psychol Psychiatry. 2011 Nov;52(11):1184-94. doi: 10.1111/j.1469-7610.2011.02413.x. Epub 2011 Apr 19. PubMed 21501168 ↗
  • Blankestein A, van der Rijken R, Eeren HV, Lange A, Scholte R, Moonen X, De Vuyst K, Leunissen J, Didden R. Evaluating the effects of multisystemic therapy for adolescents with intellectual disabilities and antisocial or delinquent behaviour and their parents. J Appl Res Intellect Disabil. 2019 May;32(3):575-590. doi: 10.1111/jar.12551. Epub 2019 Jan 8. PubMed 30620111 ↗
  • Blankestein A, Lange A, van der Rijken R, Scholte R, Moonen X, Didden R. Brief report: Follow-up outcomes of multisystemic therapy for adolescents with an intellectual disability and the relation with parental intellectual disability. J Appl Res Intellect Disabil. 2020 May;33(3):618-624. doi: 10.1111/jar.12691. Epub 2019 Dec 28. PubMed 31883357 ↗
  • De Ruiter KP, Dekker MC, Douma JCH, Verhulst FC, Koot HM. Development of parent- and teacher-reported emotional and behavioural problems in young people with intellectual disabilities: Does level of intellectual disability matter? J Appl Res Intellect Disabil. 2008; 21(1): 70-80.
  • Wallander JL, Dekker MC, Koot HM. Psychopathology in children and adolescents with intellectual disability: Measurement, prevalence, course, and risk. International Review of Research in Mental Retardation. 2003; 26: 93-134.
  • Blankestein A, Van der Rijken R, De Vuyst K, De Bruijn J, Moonen X, Leunissen J, Didden R. Multisysteemtherapie voor jongeren met een licht verstandelijke beperking en hun ouders: Een onderzoek naar de effectiviteit van een ambulante systeemgerichte interventie. Directieve Therapie. 2016; 36(3): 204-219. Dutch.
  • Dekker MC. Short Review: Psychopathology in young people with mild ID or borderline intellectual functioning: Research findings from representative (clinical) samples & future needs. Academische Werkplaats Kajak. 2019.
  • Henggeler SW, Schoenwald SK, Borduin CM, Rowland MD, Cunningham PB. Multisystemic therapy for antisocial behavior in children and adolescents. 2nd ed. New York: The Guilford Press; 2009.
  • Kaal HL, Overvest N, Boertjes MJ. Beperkt in de keten: Mensen met een licht verstandelijke beperking in de strafrechtsketen [People with mild intellectual disability in the justice system]. 2nd ed. Amsterdam: Boom Lemma; 2014.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06032455
Lead sponsor
De Viersprong
Collaborators
Stichting tot Steun, Koraal, Prisma, MST-Netherlands/Belgium, Radboud University Medical Center, Pactum
Responsible party
Sponsor
First posted
Sep 13, 2023
Start date
Sep 4, 2023
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Apr 13, 2026

Study contacts

Annemarieke Blankestein, PhD
Contact
annemarieke.blankestein@deviersprong.nl
+31629392787
Dineke Feenstra, PhD
principal investigator · De Viersprong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion